Αποτελέσματα Αναζήτησης
16 Σεπ 2024 · Moderna COVID-19 vaccine 2024-2025 formula is authorized for people ages 6 months through 11 years. Spikevax is approved for people age 12 and older. The vaccines that help protect against COVID-19 are safe and effective based on clinical trials and continued monitoring.
24 Απρ 2022 · To counteract reverse zoonosis, we developed the first COVID-19 subunit vaccines for dogs, which are representative companion animals, and the vaccine includes the SARS-CoV-2 recombinant protein of whole S1 protein and the receptor-binding domain (RBD).
The objective of this review is to provide an up-to-date comparative analysis of the characteristics, adverse events, efficacy, effectiveness, and impact of the variants of concern on the following 19 COVID-19 vaccines: mRNA vaccines (BNT16b2, mRNA-1273, CVnCoV), viral vector vaccines (AZD1222, Sputnik V, Sputnik V Light, Ad5-nCoV (Convidecia ...
4 Οκτ 2024 · Pfizer and Moderna vaccines are both safe and have similar effectiveness at preventing COVID-19 illness. Clinical trial data when they were first released in December 2020 showed 95%...
22 Ιουν 2020 · COVID-19. Preclinical data from SARS-CoV-2 mRNA vaccine. Nicolas Vabret. Nature Reviews Immunology 20, 461 (2020) Cite this article. 15k Accesses. 34 Altmetric. Metrics....
6 Ιαν 2021 · Overview. Spikevax is a vaccine for preventing coronavirus disease 2019 (COVID-19) in people from the age of 6 months. The originally authorised Spikevax contains elasomeran, a molecule called messenger RNA (mRNA) with instructions for producing a protein from the original strain of SARS-CoV-2, the virus that causes COVID-19.
Implications of all the available evidence. Primary series vaccination with two doses mRNA-1273 appears to be superior to BNT162b2 against infection and hospitalization related to the Alpha and Delta SARS-CoV-2 variants.
